Tissue inhibitor of metalloproteinase-1 (TIMP-1) polymorphisms in a Caucasian population with abdominal aortic aneurysm

World Journal of Surgery

Volumn 31, Issue 11, 2007, Pages 2248-2254

  Hinterseher, Irene ^a   Krex, Dietmar ^a   Kuhlisch, Eberhard ^a   Schmidt, Karl G ^a   Pilarsky, Christian ^a   Schneiders, Wolfgang ^a   Saeger, Hans D ^a   Bergert, Hendrik ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRON; MALE; NUCLEOTIDE SEQUENCE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 35448964331     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9209-x     Document Type: Article

References (40)

1. Bickerstaff LK, Hollier LH, Van Peenen HJ, et al. (1984) Abdominal aortic aneurysms: The changing natural history. J Vasc Surg 1:6-12
2. Mitchell M, Rutherford R, Krupski W (1995) Infrarenal aortic aneurysms. In: Rutherford R (ed), Vascular surgery. Philadelphia, WB Saunders, pp 1032-1060
3. Darling RC III, Brewster DC, Darling RC, et al. (1989) Are familial abdominal aortic aneurysms different? J Vasc Surg 10:39-43
4. Webster EL, Ferrell RE, St. Jean PL, et al. (1991) Ultrasound screening of first-degree relatives of patients with an abdominal aortic aneurysm. J Vasc Surg 13:9-14
5. Johansen K, Koepsell T (1986) Familial tendency for abdominal aortic aneurysm. JAMA 256:1934-1936
6. McKusick VA (1991) The defect in Marfan syndrome. Nature 352:279-281
7. Superti-Furga A, Steinmann B, Ramirez F, et al. (1989) Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV. Hum Genet 82:104-108
8. Tromp G, Wu Y, Prockop DJ, et al. (1993) Sequencing of cDNA from 50 unrelated patients reveals that mutations in the triple-helical domain of type III procollagen are an infrequent cause of aortic aneurysms. J Clin Invest 91:2539-2545
9. Crowther M, Brindle N, Sayers R, et al. (1996) Aneurysmal smooth muscle cells exhibit increased matrix metalloproteinase-2 production in vitro. Ann N Y Acad Sci 800:283-285
10. Freestone T, Turner RJ, Coady A, et al. (1995) Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol 15:1145-1151
11. Dobrin PB, Mrkvicka R (1994) Failure of elastin or collagen as possible critical connective tissue alterations underlying aneurysmal dilatation. Cardiovasc Surg 2:484-488
12. Busuttil RW, Abou-Zamzam A, Machleder HI (1980) Collagenase activity of the human aorta. Arch Surg 115:1373-1378
13. Keeling W, Armstrong P, Stone P, et al. (2005) An overview of matrix metalloproteinases in the pathogenesis and treatment of abdominal aortic aneurysms. Vasc Endovascular Surg 39:457-464
14. Sandford RM, Bown MJ, London NJ, et al. (2007) The genetic basis of abdominal aortic aneurysms: A review. Eur J Vasc Endovasc Surg 33:381-390
15. Davis VA, Persidskaia R, Baca-Regen L, et al. (1998) Matrix metalloproteinase-2 production and its binding to the matrix are increased in abdominal aortic aneurysms. Thromb Vasc Biol 18:1625-1633
16. McMillan WD, Patterson BK, Keen RR, et al. (1995) In situ localization and quantification of seventy-two-kilodalton type IV collagenase in aneurysmal, occlusive, and normal aorta. J Vasc Surg 22:295-305
17. Patel MI, Melrose J, Ghosh P, et al. (1996) Increased synthesis of matrix metalloproteinases by aortic smooth muscle cells is implicated in the etiopathogenesis of abdominal aortic aneurysms. J Vasc Surg 24:82-92
18. Sakalihasan N, Delvenne P, Nusgens BV, et al. (1996) Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 24:127-133
19. Nakamura M, Tachieda R, Niinuma H, et al. (2000) Circulating biochemical marker levels of collagen metabolism are abnormal in patients with abdominal aortic aneurysm. Angiology 51:385-392
20. Silence J, Collen D, Lijnen HR (2002) Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) gene. Circ Res 90:897-903
21. Allaire E, Forough R, Clowes M, et al. (1998) Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413-1420
22. Eskandari MK, Vijungco JD, Flores A, et al. (2004) Enhanced abdominal aortic aneurysm in TIMP-1-deficient mice. J Surg Res 123:289-293
23. Brophy CM, Marks WH, Reilly JM, et al. (1991) Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: A preliminary report. J Surg Res 50:653-657
24. Defawe OD, Colige A, Lambert CA, et al. (2003) Timp-2 and pai-1 mRNA levels are lower in aneurysmal as compared to athero-occlusive abdominal aortas. Cardiovasc Surg 60:205-213
25. McMillan WD, Pearce WH (1999) Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 29:122-127; discussion 127-129
26. Brew K, Dinakarpandian D, Nagase H (2000) Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta 1477:267-283
27. den Dunnen J, Antonarakis E (2001) Nomenclature for the description of human sequence variations. Hum Genet 109:121-124
28. Krex D, Röhl H, König I, et al. (2003) Tissue inhibitor of metalloproteinases-1, -2, and -3 polymorphisms in a white population with intracranial aneurysms. Stroke 34:2817-2821
29. Jones K, Brull D, Brown L, Sian M, et al. (2001) Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms. Circulation 103:2260-2265
30. Hinterseher I, Bergert H, Kuhlisch E, et al. (2006) Matrix metalloproteinase 2 polymorphisms in a caucasian population with abdominal aortic aneurysm. J Surg Res 133:121-128
31. Yoon S, Tromp G, Vongpunsawad S, et al. (1999) Genetic analysis of MMP3, MMP9 and PAI-1 in finnish patients with abdominal aortic or intracranial aneurysms. Biochem Biophys Res Commun 265:563-568
32. Ogata T, Shibamura H, Tromp G, et al. (2005) Genetic analysis of polymorphisms in biologically relevant candidate genes in patients with abdominal aortic aneurysms. J Vasc Surg 41:1036-1042
33. Armani C, Curcio M, Barsotti MC, et al. (2007) Polymorphic analysis of the matrix metalloproteinase-9 gene and susceptibility to sporadic abdominal aortic aneurysm. Biomed Pharmacother 61:268-271
34. Fatini C, Pratesi G, Sofi F, et al. (2005) ACE dd genotype: A predisposing factor for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 29:227-232
35. Tilson MD, Reilly JM, Brophy CM, et al. (1993) Expression and sequence of the gene for tissue inhibitor of metalloproteases in patients with abdominal aortic aneurysms. J Vasc Surg 18:266-270
36. Wang X, Tromp G, Cole CW, et al. (1999) Analysis of coding sequences for tissue inhibitor of metalloproteinases 1 (TIMP1) and 2 (TIMP2) in patients with aneurysms. Matrix Biol 18:121-124
37. Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865-872
38. Powell JT (2006) Genes predisposing to rapid aneurysm growth. Ann N Y Acad Sci 1085:236-241
39. Ernst C (1993) Abdominal aortic aneurysm. N Engl J Med 328:1167-1172
40. Rebbeck TR, Martinez ME, Sellers TA, et al. (2004) Genetic variation and cancer: Improving the environment for publication of association studies. Cancer Epidemiol Biomarkers Prev 13:1985-1986